Tetraphase

La Jolla to acquire Tetraphase Pharma
La Jolla to acquire Tetraphase Pharma
Seeking Alpha
La Jolla Pharmaceutical
M&A
Tetraphase
Flag link:
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Xconomy
Melinta Therapeutics
Tetraphase
M&A
antibiotics
Flag link:
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
Flag link:
A Covid-19 threat to business acquisitions
A Covid-19 threat to business acquisitions
EP Vantage
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Flag link:
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
antibiotics
Tetraphase
M&A
AcelRx
Flag link:
Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M
Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M
Endpoints
Idorsia
ACT-541468
insomnia
Tetraphase
Flag link:
​How Paratek hopes to succeed in antibiotics despite Tetraphase’s fail
​How Paratek hopes to succeed in antibiotics despite Tetraphase’s fail
Bizjournals.com
Paratek
Tetraphase
antibiotics
omadacycline
FDA
Flag link:
10 Worst NASDAQ Biotech Stocks in the Third Quarter
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
Flag link:
4 New Big FDA Decisions Expected in September
4 New Big FDA Decisions Expected in September
24/7 Wall St
FDA
Tetraphase
VTI208
Vital Therapies
Conatus Pharmaceuticals
Lexicon Pharmaceuticals
telotristat
Flag link: